User profiles for Stuart Moore
Stuart J MooreUniversity of Washington Verified email at uw.edu Cited by 73 |
The attenuation rates of ocean waves in the marginal ice zone
…, DJ Goodman, AM Cowan, SC Moore - Journal of …, 1988 - Wiley Online Library
During field operations in the Greenland and Bering Seas in 1978, 1979 and 1983, a
number of experiments were carried out in which wave energy was measured along a line of …
number of experiments were carried out in which wave energy was measured along a line of …
Direct measurement of the attenuation of ocean waves by pack ice
VA Squire, SC Moore - Nature, 1980 - nature.com
Early experimental work in the Antarctic 1 using a ship-borne wave recorder has shown that
pack ice can significantly attenuate incoming ocean waves, particularly those of shorter …
pack ice can significantly attenuate incoming ocean waves, particularly those of shorter …
PFOS destruction in a continuous supercritical water oxidation reactor
Effective end-of-life technologies are needed for remediation of PFAS-containing byproducts
and wastewater effluent streams. We describe a continuous flow supercritical water …
and wastewater effluent streams. We describe a continuous flow supercritical water …
[HTML][HTML] Activity, splice variants, conserved peptide motifs, and phylogeny of two new α1, 3-fucosyltransferase families (FUT10 and FUT11)
R Mollicone, SEH Moore, N Bovin… - Journal of biological …, 2009 - ASBMB
We report the cloning of three splice variants of the FUT10 gene, encoding for active α-l-fucosyltransferase-isoforms
of 391, 419, and 479 amino acids, and two splice variants of the …
of 391, 419, and 479 amino acids, and two splice variants of the …
Destruction and defluorination of PFAS matrix in continuous-flow supercritical water oxidation reactor: Effect of operating temperature
Cleanup and disposal of stockpiles and waste streams containing per- and polyfluoroalkyl
substances (PFAS) require effective end-of-life destruction/mineralization technologies. Two …
substances (PFAS) require effective end-of-life destruction/mineralization technologies. Two …
[HTML][HTML] Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose: Man7GlcNAc2-PP-dolichyl mannosyltransferase
Type I congenital disorders of glycosylation (CDG I) are diseases presenting multisystemic
lesions including central and peripheral nervous system deficits. The disease is characterized …
lesions including central and peripheral nervous system deficits. The disease is characterized …
[HTML][HTML] A deficiency in dolichyl-P-glucose: Glc1Man9GlcNAc2-PP-dolichyl α3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation
The underlying causes of type I congenital disorders of glycosylation (CDG I) have been
shown to be mutations in genes encoding proteins involved in the biosynthesis of the dolichyl-…
shown to be mutations in genes encoding proteins involved in the biosynthesis of the dolichyl-…
[HTML][HTML] A case of fatal Type I congenital disorders of glycosylation (CDG I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity
Background Type I congenital disorders of glycosylation (CDG-I) are mostly complex multisystemic
diseases associated with hypoglycosylated serum glycoproteins. A subgroup harbour …
diseases associated with hypoglycosylated serum glycoproteins. A subgroup harbour …
Free oligosaccharide regulation during mammalian protein N-glycosylation
I Chantret, SEH Moore - Glycobiology, 2008 - academic.oup.com
… Stuart EH Moore Stuart EH Moore 3 … et al. 2007) and elimination of oligosaccharide
waste generated during protein N-glycosylation (Moore 1999). In fact, during protein N-glycosylation, …
waste generated during protein N-glycosylation (Moore 1999). In fact, during protein N-glycosylation, …
[HTML][HTML] Cytosol-to-lysosome transport of free polymannose-type oligosaccharides: kinetic and specificity studies using rat liver lysosomes
A Saint-Pol, P Codogno, SEH Moore - Journal of Biological Chemistry, 1999 - ASBMB
In hepatocellular carcinoma HepG2 cells, free polymannose-type oligosaccharides appearing
in the cytosol during the biosynthesis and quality control of glycoproteins are rapidly …
in the cytosol during the biosynthesis and quality control of glycoproteins are rapidly …